Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Tianjiu Industry Group is a leading Chinese biotechnology company specializing in the research, development, and large-scale production of functional food ingredients and nutritional supplements. The company is particularly recognized for its expertise in bio-enzymatic hydrolysis, which it uses to produce a wide range of bioactive peptides, including those derived from soy, corn, peas, and collagen. These products serve the global healthcare, pharmaceutical, and food industries, targeting applications in skin health, sports nutrition, and metabolic wellness. Headquartered in Heze, Shandong, the group operates state-of-the-art manufacturing facilities that comply with international standards such as GMP, ISO, and HACCP. Their commitment to innovation is supported by collaborations with academic institutions to advance the application of biotechnology in human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Tianjiu Industry Group.